Adapting Head and Neck Cancer Management in the Time of COVID-19
Int J Radiat Oncol Biol Phys
.
2020 Jul 15;107(4):628-630.
doi: 10.1016/j.ijrobp.2020.04.017.
Epub 2020 Apr 18.
Authors
Hisham Mehanna
1
,
Maura Gillison
2
,
Anne W M Lee
3
,
Sandra V von Zeidler
4
,
Sandro Porceddu
5
;
Head and Neck International Group (HNCIG)
Affiliations
1
Institute for Head and Neck Studies and Education, University of Birmingham, Birmingham, United Kingdom. Electronic address: h.mehanna@bham.ac.uk.
2
University of Texas MD Anderson Cancer Center, Houston, Texas.
3
Department of Clinical Oncology, University of Hong Kong, Hong Kong, China.
4
Postgraduate Program in Biotechnology, Federal University of Espírito Santo, Vitória, Brazil.
5
University of Queensland, Princess Alexandra Hospital, Brisbane, Australia.
PMID:
32589989
PMCID:
PMC7165274
DOI:
10.1016/j.ijrobp.2020.04.017
No abstract available
Publication types
Editorial
Comment
MeSH terms
Betacoronavirus
COVID-19
Consensus
Coronavirus Infections*
Head and Neck Neoplasms*
Humans
Pandemics*
Pneumonia, Viral*
SARS-CoV-2